Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Dermatology|June 23, 2019
Intratumoral and Combination Therapy in Melanoma and Other Skin CancersArielle Oglesby, Alain P Algazi, Adil I Daud
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Biology and treatment of primary central nervous system lymphomaAlain P Algazi, Cigall Kadoch, James L Rubenstein
Cancer Management and Research|December 29, 2010
Treatment of cutaneous melanoma: current approaches and future prospectsAlain P Algazi, Christopher W Soon, Adil I Daud
Journal for Immunotherapy of Cancer|September 24, 2016
Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockadeKaty K Tsai, Miguel H Pampaloni, Charity Hope, et al.
Pigment Cell & Melanoma Research|September 19, 2017
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanomaAlain P Algazi, Rosaura Esteve-Puig, Adi Nosrati, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|April 27, 2018
Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinomaMelody J Xu, Tara J Wu, Annemieke van Zante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced CancerLee S Rosen, Jonathan W Goldman, Alain P Algazi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2024
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell CarcinomaChristopher A Barker, Suzanne Dufault, Sarah T Arron, et al.
Pageof 5